Talphera to Join A.G.P. Virtual Healthcare Conference

SAN MATEO, Calif., May 16, 2024 - Talphera, Inc. (Nasdaq: TLPH), a specialty pharmaceutical firm, has announced its participation in a fireside chat at the A.G.P. Virtual Healthcare conference scheduled for May 21, 2024, at 10:40 a.m. ET. The company, known for developing and commercializing innovative therapies for medically supervised environments, will discuss its advancements and ongoing projects.

The presentation details for the conference are as follows:
- Date: Tuesday, May 21, 2024
- Time: 10:40 a.m. ET
- Format: Fireside Chat

Talphera, Inc. is dedicated to creating novel treatments aimed at improving patient care in clinical settings. The company's primary product candidate, Niyad™, is a lyophilized formulation of nafamostat, under investigation as an anticoagulant for extracorporeal circuits. This product has garnered Breakthrough Device Designation from the FDA, a testament to its potential impact and innovation.

In addition to Niyad™, Talphera is advancing two other significant products. The first, Fedsyra™, is a pre-filled ephedrine syringe designed to address specific medical needs efficiently. The second, known as PFS-02, is a pre-filled phenylephrine syringe. Both of these products are in-licensed from Aguettant, a collaborative partner, highlighting Talphera’s commitment to enhancing its portfolio with effective and convenient therapeutic solutions.

This announcement is specifically targeted at the investment community, underscoring Talphera's ongoing engagement and transparency with its stakeholders. The company's progress in developing these cutting-edge medical products positions it as a significant player in the pharmaceutical industry, particularly in the niche of medically supervised therapeutic solutions.

Talphera’s participation in the A.G.P. Virtual Healthcare conference provides a platform to showcase its innovative pipeline and strategic initiatives to a broader audience. Through this engagement, Talphera aims to highlight the therapeutic potential and clinical benefits of its products, reinforcing its mission to address critical needs in medical care.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!